« previous next »
Pages: [1]   Go Down

Author Topic: NY Times: Risks of Anemia Drugs for Patients With Cancer to Get More Scrutiny  (Read 1343 times)

0 Members and 1 Guest are viewing this topic.

Offline feedbot

  • Επίλεκτο μέλος
  • *****
  • Posts: 6686
  • Κάπνισμα: Δεν κάπνισα ποτέ
NY Times: Risks of Anemia Drugs for Patients With Cancer to Get More Scrutiny
« on: 12 Mar, 2008, 20:47:29 »
Risks of Anemia Drugs for Patients With Cancer to Get More Scrutiny
     

An F.D.A. advisory committee will consider placing further limits on the use of the Amgen drugs Epogen and Aranesp and the Johnson & Johnson drug Procrit.
     

http://www.nytimes.com/2008/03/12/business/12anemia.html?ex=1363060800&en=10e045c8360a66c8&ei=5088&partner=rssnyt&emc=rss
     
Logged
Pages: [1]   Go Up
« previous next »
 

Cookies help us provide you a better browsing experience. By using our site, you consent to the use of cookies by us.